Joseph Skelton

Joseph Skelton has nearly ten years of investment banking experience with a focus on the life sciences vertical. During his career, he has advised on transactions totaling more than $20 billion. He most recently served as a Senior Vice President in the Healthcare Investment Banking Group at Truist Securities, covering the biopharma sector. During his tenure at Truist, he served on many of the franchise-making deals of the Healthcare group across both M&A advisory as well as strategic capital raising. Prior to joining Truist, Mr. Skelton was a member of the Healthcare Investment Banking Group at Cantor Fitzgerald. During his tenure at Cantor, he focused on providing M&A advisory services as well as strategic capital raising. Mr. Skelton has also held roles in Corporate Development at Amneal Pharmaceuticals where he helped execute the strategic initiatives of Amneal. He holds a Master of Science in Accounting and a Bachelors of Sciences in Business & Economics from Lehigh University.